| 000 | 01819 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515154714.0 | ||
| 264 | 0 | _c20090318 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1475-2840 | ||
| 024 | 7 |
_a10.1186/1475-2840-8-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGurney, Alison M | |
| 245 | 0 | 0 |
_aEffects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries. _h[electronic resource] |
| 260 |
_bCardiovascular diabetology _cJan 2009 |
||
| 300 |
_a4 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCalcium Signaling _xdrug effects |
| 650 | 0 | 4 |
_aCarbachol _xpharmacology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xphysiopathology |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xcomplications |
| 650 | 0 | 4 |
_aDinoprost _xpharmacology |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
| 650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aNitroglycerin _xpharmacology |
| 650 | 0 | 4 |
_aPhenylephrine _xpharmacology |
| 650 | 0 | 4 |
_aPotassium _xpharmacology |
| 650 | 0 | 4 |
_aPulmonary Artery _xdrug effects |
| 650 | 0 | 4 |
_aPulmonary Circulation _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aSerotonin _xpharmacology |
| 650 | 0 | 4 | _aStreptozocin |
| 650 | 0 | 4 |
_aVascular Resistance _xdrug effects |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aHowarth, Frank C | |
| 773 | 0 |
_tCardiovascular diabetology _gvol. 8 _gp. 4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1475-2840-8-4 _zAvailable from publisher's website |
| 999 |
_c18606317 _d18606317 |
||